Who owns Pluristem Therapeutics Inc?
- Ticker: PSTI
- CUSIP Number: 72940r300
Tip: Access positions for across all investors
Analyze quarterly positions in Pluristem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pluristem Therapeutics stock
Who bought or sold Pluristem Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Nia Impact Advisors | 838k | $1.7M | 11% | Mar 2022 | ||
| Meitav Dash Investments | 168k | $347k | 0% | Mar 2022 | ||
| Jane Street | 138k | $285k | 75% | Mar 2022 | ||
| CCM Partners | 129k | $266k | -46% | Mar 2022 | ||
| Citadel Advisors | 119k | $246k | -42% | Mar 2022 | ||
| Green Alpha Advisors | 78k | $162k | 17% | Mar 2022 | ||
| Renaissance Technologies | 76k | $157k | -68% | Mar 2022 | ||
| Values First Advisors | 50k | $102k | 17% | Mar 2022 | ||
| Zurcher Kantonalbank | 30k | $63k | -1% | Mar 2022 | ||
| Geode Capital Management | 25k | $52k | 0% | Mar 2022 | ||
| Townsquare Capital | 24k | $50k | 100% | Mar 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Pluristem Therapeutics? |
||||||
| Morgan Stanley | 15k | $31k | 100% | Mar 2022 | ||
| Advisor Group Holdings | 4.9k | $0 | -6% | Mar 2022 | ||
| Jpmorgan Chase & Co | 3.6k | $8.0k | 100% | Mar 2022 | ||
| Banque Cantonale Vaudoise | 3.2k | $7.0k | 0% | Mar 2022 | ||
| Baldwin Brothers | 1.5k | $3.0k | 15% | Mar 2022 | ||
| Endurance Wealth Management | 1.5k | $3.0k | 0% | Mar 2022 | ||
| Newbridge Financial Services Group | 1.2k | $2.0k | 100% | Mar 2022 | ||
| Steward Partners Investment Advisory | 504.00 | $999.986400 | 0% | Mar 2022 | ||
| Us Bancorp | 500.00 | $1.0k | 0% | Mar 2022 | ||
| Winch Advisory Services | 206.00 | $0 | 0% | Mar 2022 | ||
| BDO Wealth Advisors | 100.00 | $0 | 0% | Mar 2022 | ||
| Captrust Financial Advisors | 100.00 | $0 | 100% | Mar 2022 | ||
| Proequities | 0 | $0 | -100% | Mar 2022 | ||
Who sold out of Pluristem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ARK Investment Management | Sep 2021 | 925k | $2.5M |
| GSA Capital Partners | Sep 2021 | 258k | $683k |
| Sumitomo Mitsui Trust Holdings | Dec 2021 | 99k | $144k |
| Nikko Asset Management Americas | Dec 2021 | 99k | $145k |
| Walleye Trading | Sep 2021 | 66k | $175k |
| Millennium Management | Sep 2021 | 44k | $116k |
| D. E. Shaw & Co | Dec 2021 | 42k | $62k |
| Group One Trading | Sep 2021 | 41k | $108k |
| HighTower Advisors | Sep 2021 | 30k | $82k |
| Simplex Trading | Dec 2021 | 17k | $25k |
| SG3 Management | Dec 2021 | 14k | $21k |
| Archford Capital Strategies | Sep 2021 | 13k | $35k |
| Walleye Trading Advisors | Dec 2021 | 12k | $18k |
| Cutler | Dec 2021 | 7.5k | $10k |
| Wells Fargo & Company | Sep 2021 | 6.0k | $16k |
| Harbour Investments | Sep 2021 | 3.0k | $8.0k |
| Bank of America Corporation | Dec 2021 | 1.4k | $1.4k |
| NEXT Financial | Sep 2021 | 500.00 | $1.0k |
| TFC Financial Management | Sep 2021 | 149.00 | $0 |